lysophosphatidic acid has been researched along with Cirrhosis, Liver in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baader, M; Bretschneider, T; Broermann, A; Kuttruff, CA; Mark, M; Rippmann, JF; Stierstorfer, B | 1 |
| Chen, GX; Yang, F | 1 |
| Yatomi, Y | 1 |
| Ahmad, NB; Baba, H; Bain, G; Baumert, TF; Beppu, T; Bian, CB; Chuang, WL; Chung, RT; Colombo, M; Dai, CY; El-Abtah, M; Erstad, DJ; Friedman, SL; Fuchs, BC; Ghoshal, S; Goossens, N; Gunasekaran, G; Higashi, T; Hoshida, H; Hoshida, Y; Iavarone, M; Kim, RS; Kobayashi, M; Koh, AP; Kumada, H; Lanuti, M; Lauwers, GY; Lee, Y; Llovet, JM; Mahajan, M; Nair, VD; Nakagawa, S; Sangiovanni, A; Schwarz, ME; Song, WM; Subramanian, A; Sun, X; Tager, AM; Tanabe, KK; Venkatesh, A; Villanueva, A; Wei, L; Yamada, S; Yu, ML; Zhang, B | 1 |
| Bae, SS; Birnbaum, MJ; Cho, M; Do, KH; Kim, CD; Kim, EK; Kim, JH; Kim, MS; Suh, DS; Yun, SJ | 1 |
| Ikeda, H; Yatomi, Y | 1 |
| Aoki, J; Arai, H; Arai, M; Fujiwara, K; Hama, K; Ikeda, H; Kume, Y; Nakamura, K; Nishikawa, T; Ohkawa, R; Okudaira, S; Omata, M; Tanaka, M; Tejima, K; Tomiya, T; Watanabe, N; Yanase, M; Yatomi, Y | 1 |
3 review(s) available for lysophosphatidic acid and Cirrhosis, Liver
| Article | Year |
|---|---|
Production of extracellular lysophosphatidic acid in the regulation of adipocyte functions and liver fibrosis.
Topics: Adipocytes; Animals; Humans; Insulin Resistance; Liver Cirrhosis; Lysophosphatidylcholines; Lysophospholipids; Models, Animal; Obesity; Phosphoric Diester Hydrolases; Receptors, Lysophosphatidic Acid; Signal Transduction | 2018 |
[The Laboratory Medicine of Lipid Mediators].
Topics: Acute Coronary Syndrome; Arthritis, Rheumatoid; Biomarkers; Clinical Laboratory Techniques; Female; Humans; Liver Cirrhosis; Lysophospholipids; Male; Phosphoric Diester Hydrolases | 2015 |
Autotaxin in liver fibrosis.
Topics: Carcinoma, Hepatocellular; Hepatic Stellate Cells; Humans; Liver Cirrhosis; Lysophospholipids; Phosphoric Diester Hydrolases; Pruritus | 2012 |
4 other study(ies) available for lysophosphatidic acid and Cirrhosis, Liver
| Article | Year |
|---|---|
Characterization of the properties of a selective, orally bioavailable autotaxin inhibitor in preclinical models of advanced stages of liver fibrosis.
Topics: Administration, Oral; Animals; Biological Availability; Caco-2 Cells; Carbon Tetrachloride; Drug Evaluation, Preclinical; Hepatic Stellate Cells; Humans; Liver Cirrhosis; Lysophospholipids; Male; Phosphoric Diester Hydrolases; Rats; Rats, Sprague-Dawley | 2018 |
Molecular Liver Cancer Prevention in Cirrhosis by Organ Transcriptome Analysis and Lysophosphatidic Acid Pathway Inhibition.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Gene Expression Profiling; Gene Regulatory Networks; Genetic Predisposition to Disease; Humans; Liver Cirrhosis; Liver Neoplasms; Lysophospholipids; Rats; Risk Factors; Signal Transduction; Xenograft Model Antitumor Assays | 2016 |
Lysophosphatidic acid induces cell migration through the selective activation of Akt1.
Topics: Adult; Aged; Animals; Ascites; Cell Movement; Cells, Cultured; Embryo, Mammalian; Enzyme Activation; Female; Humans; Liver Cirrhosis; Lysophospholipids; Mice; Middle Aged; Ovarian Neoplasms; Phosphatidylinositol 3-Kinases; Pregnancy; Proto-Oncogene Proteins c-akt; Substrate Specificity | 2008 |
Both plasma lysophosphatidic acid and serum autotaxin levels are increased in chronic hepatitis C.
Topics: Aged; Female; Hepatitis C, Chronic; Humans; Hyaluronic Acid; Liver Cirrhosis; Liver Function Tests; Lysophospholipids; Male; Middle Aged; Multienzyme Complexes; Phosphodiesterase I; Phosphoric Diester Hydrolases; Platelet Count; Pyrophosphatases; Substrate Cycling | 2007 |